|
Community Preventive Services Task Force (CPSTF)
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
OD/DPCPSI/ODP, OD/DPCPSI
|
The Community Preventive Services Task Force (CPSTF) is an independent, non-federal panel of prevention experts that uses information from rigorously conducted systematic evidence reviews to make public health recommendations for preventive services that are delivered in community settings. These recommendations are intended to inform public health decision-making about policy, practice, and research priorities for community preventive services. Recommendations from the CPSTF are published in The Guide to Community Preventive Services. The Office of Disease Prevention (ODP) represents NIH as an official liaison member and works with the CDC and CPSTF members to ensure that recommendations represent the views, concerns, and needs of the NIH and our constituents. ODP staff also serve on, or recommend NIH scientists to serve on systematic evidence review teams, and help translate CPSTF recommendations and insufficient evidence findings into actions.
|
|
Computational Toxicology for NIH Medications Discovery
|
Research Initiative
|
FDA
|
NIDA
|
Through an inter-agency agreement, the Food and Drug Administration (FDA) provides structure-activity, relationship-based toxicity predictions for compounds that are under evaluation in the National Institute on Drug Abuse (NIDA) Addiction Treatment Discovery Program. On a limited basis, other NIH ICs may utilize this resource by working through NIDA.
|
|
Computer-aided Diagnosis for Radiology Images
|
Research Initiative
|
FDA
|
CC
|
This collaboration focuses on the improvement of computer-aided diagnosis for radiology images. Specific applications include computer-aided polyp detection for computed tomography (CT )colonography, improvements in the conduct and analysis of observer performance experiments using radiology images, and the use and development of advanced machine learning and receiver operating characteristics methods with application to computer-aided diagnosis.
|
|
Consensus-Based Entity (CBE) Committee
|
Committee, Work group, Advisory group, or Task Force
|
ACL, AHRQ, CDC, CMS, HRSA, OS
|
NLM
|
The Consensus-Based Entity (CBE) Committee is a Department of Health and Human Services (HHS) wide entity, chaired by the Office of the Assistant Secretary for Planning and Evaluation (ASPE), to provide oversight and input into the execution of ASPE’s legislation-mandated contract with the National Quality Forum (the Consensus-Based Entity) for establishing quality and performance measures. the National Library of Medicine (NLM) participates as an invited member.
|
|
Content Standards Workgroup of the Health Information Technology (HIT) Standards Committee
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NLM
|
The Content Standards Workgroup of the Health Information Technology (HIT) Standards Committee is part of the Federal Advisory Committee that is charged with making recommendations to ONC on standards, implementation specifications, and certification criteria for the electronic exchange and use of health information.
|
|
Council on Emergency Medical Care
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, HRSA, OS, SAMHSA
|
NIMH, NCATS, NHLBI, NICHD, NIGMS, NINDS, NLM
|
The Council on Emergency Medical Care (CEMC) is a coalition comprised of subject-matter experts and policymakers in emergency medical care from organizations across the Federal Government. The CEMC contributes to the development, advancement, and coordination of federal strategies, policies, and priorities relating to emergency medical care to improve the nation’s emergency care system.
|
|
Countering Biothreats PCC on Gene Editing and Synthesis (CBT PCC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, OS
|
OD/OSP
|
Discusses policy options related to gene editing and synthesis.
|
|
Countering Biothreats sub-PCC on Gene Editing and Synthesis (CBT sub-PCC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, OS
|
OD/OSP
|
Discusses policy options related to gene editing and synthesis; supports the Countering Biothreats PCC on Gene Editing and Synthesis (CBT PCC) group.
|
|
Countermeasures Against Chemical Threats (CounterACT) Research Network
|
Research Initiative
|
CDC, FDA, OS
|
NINDS, NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS, NLM
|
The CounterACT program is a translational research program supporting basic, translational, and clinical research aimed at the discovery and identification of better therapeutic medical countermeasures and diagnostic technologies against chemical threat agents, which facilitates their movement through the regulatory process in collaboration with other federal departments and agencies, such as the Biomedical Advanced Research and Development Authority (HHS BARDA). The program includes a comprehensive network of Research Centers of Excellence, individual co-operative research projects, small business innovation research grants, contracts, and interagency agreements with the Department of Defense. Among other activities, the National Institute of Neurological Disorders and Stroke (NINDS) organizes an annual meeting of investigators supported by the program allowing researchers to share information, encourage collaboration, and enable the National Institutes of Health (NIH) staff to evaluate the group’s progress on themes such as nerve agents, seizure detection technology, cyanide, and sulfur mustard.
|
|
Country Work in Cancer Research and Cancer Control Planning Strengthening – Kenya
|
Other
|
CDC
|
NCI, FIC, NIAID
|
Kenya has an estimated population of over 42 million. Cancer ranks third as a cause of death after infectious and cardiovascular diseases. It estimated that over 18,000 Kenyans die of cancer annually. The most common types of cancer in Kenya are cancers of the cervix, breast, esophagus, and prostate. The Ministry of Health released a National Cancer Control Strategy (2010-2015) and a National Cervical Cancer Prevention Program Strategic Plan (2012-2015). NCI looks to build upon those efforts in coordination with the many US government and non-governmental partners (NGOs) working in the country. US government agencies, including the National Cancer Institute (NCI), the National Institute of Allergy and Infectious Disease (NIAID), the Fogarty International Center (FIC), the Centers for Disease Control (CDC), and the US Agency for International Development (USAID) have a significant presence in Kenya. Between FY2010 and FY2012, there were 121 NIH or CDC awards totaling $160.1M, and USAID invested $700 million in Kenya in FY2011. At least six NCI-designated cancer centers have activities in Kenya ranging from capacity building for cancer screening and treatment to studies of cancers associated with chronic infection, including HPV. Notably, Moi University has hosted the Academic Model Providing Access to Healthcare (AMPATH) partnership, along with Indiana University (IU), since 2001. The AMPATH-Moi-IU partnership has created the largest clinical research data enterprises in the developing world and includes 18 HIV clinics in western Kenya with 2,000 new patients enrolling per month as of 2012.
|